CNXC Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

Revenue: Approximately $2.5 billion, up 1.9% on a constant currency basis and over 5% on a reported basis.
Profitability:
- Non-GAAP operating income: $295 million.
- Adjusted EBITDA: $348 million, with a margin of 13.9%.
- Non-GAAP diluted EPS: $2.61, consistent with guidance.
Cash Flow: Adjusted free cash flow was negative $145 million due to increased accounts receivable, expected to normalize in subsequent quarters. Full-year adjusted free cash flow guidance remains at $630 million to $650 million.
Shareholder Returns: Approximately $65 million returned to shareholders, including $42 million in share repurchases.

2. Strategic Updates and Business Highlights:

Concentrix reported a 61% year-over-year increase in technology wins, particularly in AI solutions.
Closed nearly 60 enterprise deals involving the iX suite, including contracts with two Fortune 50 companies.
Focus on securing complex, high-value services and leveraging proprietary technology to enhance client relationships and revenue mix.
Continued investment in AI and automation is expected to drive future growth and profitability.

3. Forward Guidance and Outlook:

Q2 2026 Revenue Guidance: Expected between $2.46 billion and $2.485 billion, implying constant currency growth of 1% to 2%.
Profitability Guidance: Non-GAAP operating income expected between $290 million and $300 million, with a margin of 11.8% to 12.1%.
Full-Year Outlook: Confidence in achieving adjusted free cash flow target and reducing net leverage to below 2.6x adjusted EBITDA by year-end.

4. Bad News, Challenges, or Points of Concern:

Declines in the technology and consumer electronics verticals, both down 6% due to lighter client volumes and shifts in service delivery.
Ongoing margin compression in the first half of 2026, with expectations for gradual improvement in the second half.
Geopolitical uncertainties have led to cautious client behavior, although current impacts on revenue are minimal.
Continued trend of clients moving operations offshore, which may initially compress margins but is expected to improve them over time.

5. Notable Q&A Insights:

AI revenue contribution is significant but difficult to quantify as clients often use multiple AI solutions.
Margin improvement is expected in the second half of 2026, driven by cost reduction actions and increased revenue from transformational deals.
The company is not currently planning further divestitures beyond the recent sale of two small nonstrategic businesses.
The healthcare vertical is facing challenges due to changes in Medicare membership, with recovery not expected for a couple of quarters.
Excess capacity negatively impacted margins by 20 to 40 basis points in Q1, with expectations for improvement as revenue grows into this capacity.

CNXC — Concentrix Corporation